Evidence map›Paper›PMID 27342689›Full record

GuidelineGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2017

Japanese gastric cancer treatment guidelines 2014 (ver. 4).

Japanese Gastric Cancer Association

8 registry-linked trialsAbstract readPractice Guideline
In one paragraph

Guideline in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 8 registered trials, which are not on this map. Cited by 1,379 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,379citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03413514 naunknown statusnot on this mapstarted 2018, after this paper: background citation

A Non-Randomized,Single Center Study to Investigate the Real World Evidence for the Maximal Cycle of Effective Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision Making

TypeinterventionalSponsorPeking UniversityRan2018 to 2023Enrolled100ConditionsGastric CancerArmsNACT, SDM, Surgery, ACT, Questionnaire
NCT03500471 completednot on this mapstarted 2018, after this paper: background citation

Safety and Feasibility Between Robotic and Laparoscopic Total Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer:A Prospective Cohort Study

TypeobservationalSponsorSouthwest Hospital, ChinaRan2018 to 2021Enrolled142ConditionsGastric CancerArmsRobotic-assisted Total Gastrectomy, Laparoscopic-assisted Total Gastrectomy
NCT03857737 nanot yet recruitingnot on this mapstarted 2019, after this paper: background citation

A Study Which Compares the Long Term and Short Term Outcomes Between Endoscopic Submucosal Dissection and Surgery in the Treatment of Early Gastric Cancer

TypeinterventionalSponsorPeking University Third HospitalRan2019 to 2029Enrolled300ConditionsEarly Gastric CancerArmsendoscopic submucosal dissection, Surgery
NCT03931044 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Fluorescence Image-Guided Lymphadenectomy Using Indocyanine Green and Near Infrared Technology in Robotic Gastrectomy

TypeinterventionalSponsorInternational Study Group on Minimally Invasive Surgery for Gastric CancerRan2019 to 2020Enrolled40ConditionsGastric Cancer, Sentinel Lymph NodeArmsImage-Guided Robotic Gastrectomy
NCT04192734 completednot on this mapstarted 2019, after this paper: background citation

A Retrospective Study for Evaluation of Real-world Efficacy and Safety of Ramucirumab Plus Paclitaxel in Patients With Locally-advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

TypeobservationalSponsorHallym University Medical CenterRan2019 to 2020Enrolled1,063ConditionsGastric or Gastroesophageal Junction Adenocarcinoma
NCT04915807 unknown statusnot on this mapstarted 2021, after this paper: background citation

A Prospective Study for Real-world Data (RWD) of Ramucirumab Plus Paclitaxel in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Typeobservational_patient_registrySponsorHallym University Medical CenterRan2021 to 2023Enrolled222ConditionsGastric Cancer, Gastroesophageal Junction AdenocarcinomaArmsRamucirumab and paclitaxel, Taxane, irinotecan, or fluoropyrimidine-based single or combined chemotherapy
NCT05161572 phase2terminatednot on this mapstarted 2021, after this paper: background citation

A Randomized Phase II Trial of Perioperative Chemoimmunotherapy Verses Perioperative Chemoimmunotherapy Plus Preoperative Chemoradiation for Locally Advanced Gastric (G) or Gastroesophageal Junction (GEJ) Adenocarcinoma

TypeinterventionalSponsorFudan UniversityRan2021 to 2022Enrolled6ConditionsStomach Neoplasms, Esophagogastric Junction Disorder, Neoadjuvant Therapy, ChemoradiotherapyArmsOxaliplatin, Tegafur-Gimeracil-Oteracil, Sintilimab, Concurrent chemoradiation, D2/R0 gastrectomy
NCT05181306 completednot on this map

Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric Cancer: A Propensity Score Matching Study

TypeobservationalSponsorSouthwest Hospital, ChinaRan2010 to 2016Enrolled430ConditionsGastric CancerArmsRobotic-assisted Total Gastrectomy with D2 Lymphadenectomy, Laparoscopic-assisted Total Gastrectomy with D2 Lymphadenectomy
3 · Its place in the literature

Who cites it

1,379 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Intraoperative corticosteroid administration for resectable gastric cancer: a multicenter, randomized, open-label, phase II/III study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Review
  19. Article
  20. Article

1,319 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Japanese Gastric Cancer Association

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlgorithmsClinical Trials as TopicCombined Modality TherapyHumansJapanStomach NeoplasmsTime Factors

Identifiers

PMID27342689
PMCPMC5215069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.